Special clinical nutrition formula for gestational hypertension and preparation method thereof

Abstract

The invention relates to a special clinical nutrition formula for gestational hypertension and a preparation method thereof. The special clinical nutrition formula comprises the following components: 25-35 parts of protein, 8-15 parts of fat, 35-45 parts of carbohydrate, 3-8 parts of dietary fiber, 0.6-1.2 parts of macroelement, 0.01-0.03 part of trace element, 0.005-0.02 part of fat-soluble vitamin, 0.08-0.2 part of water-soluble vitamin, 0.5-5 parts of dietary essence, 0.5-5 parts of medicinal-edible component, 0.1-1 part of natural plant compound and 0.1-0.4 part of new resource food, wherein the medicinal-edible component is at least one of flos chrysanthemi, sophora japonica, lotus leaf, wolfberry, oyster, phyllanthus emblica and radix puerariae; the components are made into powder in advance; the fat is made into powdered oil by a micro-capsule embedding technology. Through the screening and proportioning of the components, the nutrition formula provided by the invention can meet the comprehensive needs of a gestational hypertension patient; and meanwhile, by adding the component with a blood pressure reducing function, the blood pressure value of gestational hypertension is lowered, the risk of gestational hypertension is reduced, and the growth needs and normal development of a fetus are guaranteed.

Description

technical field [0001] The invention relates to the field of formula food for special medical purposes, in particular to a special clinical nutritional formula for pregnancy-induced hypertension and a preparation method thereof. Background technique [0002] Pregnancy-induced hypertensive syndrome is a disease unique to pregnancy, including gestational hypertension, preeclampsia, and eclampsia, mainly manifested as elevated blood pressure and proteinuria, which can harm various organs of pregnant women. Usually, most pregnant patients only have mild symptoms, but it can lead to some adverse pregnancy consequences, including premature birth, fetal growth restriction, and in severe cases, fetal death and placental abruption. In my country, the incidence of pregnancy-induced hypertension is about 9.4%, and in foreign countries it is about 7% to 12%. Most cases have symptoms such as hypertension and proteinuria after 20 weeks of pregnancy, which disappear after delivery. The di...

AI Technical Summary

Problems solved by technology

But so far there is no research report on the application of nutritional interventions to prevent pregnancy-induced hypertension

Images